Author:
Toge Tetsuya,Yamada Hirofumi,Aratani Kiyoshi,Kameda Akira,Kuroi Katsumasa,Hisamatsu Kazufumi,Hattori Takao
Publisher
Springer Science and Business Media LLC
Subject
Surgery,General Medicine,Surgery
Reference16 articles.
1. Uchida A, Hoshino T. Clinical studies on cell mediated immunity in patients with malignant disease. I. Effected immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsivenessin vitro. Cancer 1980: 45: 476–483.
2. Ishii Y, Yamaoki H, Toh K, Kikuchi K. Inhibition of tumor growthin vivo andin vitro by macrophages from rats treated with a streptococcal preparation, OK-432. Gann 1976: 67: 115–119.
3. Uchida A, Mickche M. Intrapleural administration of OK-432 in cancer patients: Activation of NK cells and reduction of suppressor cells. Int J Cancer 1983; 31: 1–5.
4. Matsubara S, Suzuki F, Ishida N. Induction of immune interferon in mice treated with a bacterial immunopotentiator, OK-432. Cancer Immunol Immunother 1979; 6: 41–45.
5. Katano M, Torisu M. Neutrophil-mediated tumor cell destruction in cancer ascites. Cancer 1982; 50: 62–68.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献